UBS Group
PBPH

UBS Group’s Portfolio Building Block World Pharma and Biotech Index ETF PBPH Stock Holding History

UBS Group’s Portfolio PBPH Stock Details PBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Buy
2,970
+1,126
+61% +$28.7K ﹤0.01% 7305
2026
Q1 		$47.1K Buy
+1,844
New +$48K ﹤0.01% 7404

Other funds holding PBPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's PBPH Position: Q2 2026 in Review

UBS Group increased its Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) stake by 61% in Q2 2026, buying an estimated $28.7K and bringing the position to 2,970 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7305.

UBS Group first reported a position in PBPH in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold PBPH as of Q2 2026.

  • UBS Group held 2,970 shares of Portfolio Building Block World Pharma and Biotech Index ETF worth $80.7K as of Q2 2026.
  • UBS Group bought 1,126 Portfolio Building Block World Pharma and Biotech Index ETF shares in Q2 2026, an estimated $28.7K.
  • Portfolio Building Block World Pharma and Biotech Index ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7305 holding.
  • UBS Group first reported a position in Portfolio Building Block World Pharma and Biotech Index ETF in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Portfolio Building Block World Pharma and Biotech Index ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.